Welcome to LookChem.com Sign In|Join Free

CAS

  • or

55-40-3

Post Buying Request

55-40-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55-40-3 Usage

Chemical Properties

Grey Solid

Check Digit Verification of cas no

The CAS Registry Mumber 55-40-3 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 5 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 55-40:
(4*5)+(3*5)+(2*4)+(1*0)=43
43 % 10 = 3
So 55-40-3 is a valid CAS Registry Number.

55-40-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-METHYL-3-(3,4-DIHYDROXYPHENYL)-DL-ALANINE

1.2 Other means of identification

Product number -
Other names rac Alpha-Methyl DOPA

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:55-40-3 SDS

55-40-3Synthetic route

DL-N-Acetyl-α-methyl-β-<3,4-dimethoxy-phenyl>-alanin
5934-66-7

DL-N-Acetyl-α-methyl-β-<3,4-dimethoxy-phenyl>-alanin

alpha-methyldopa
55-40-3

alpha-methyldopa

Conditions
ConditionsYield
(hydrolysis);
2-Amino-3-(3,4-bis-benzyloxy-phenyl)-2-methyl-propionic acid ethyl ester; hydrochloride
84713-76-8

2-Amino-3-(3,4-bis-benzyloxy-phenyl)-2-methyl-propionic acid ethyl ester; hydrochloride

alpha-methyldopa
55-40-3

alpha-methyldopa

Conditions
ConditionsYield
With hydrogenchloride; hydrogen; palladium on activated charcoal 1.) ethanol; Yield given. Multistep reaction;
(+-)-2-amino-3-<3.4-dimethoxy-phenyl>-2-methyl-propionic acid

(+-)-2-amino-3-<3.4-dimethoxy-phenyl>-2-methyl-propionic acid

alpha-methyldopa
55-40-3

alpha-methyldopa

Conditions
ConditionsYield
With hydrogen bromide
(+-)-2-amino-3-<3-hydroxy-4-methoxy-phenyl>-2-methyl-propionic acid

(+-)-2-amino-3-<3-hydroxy-4-methoxy-phenyl>-2-methyl-propionic acid

alpha-methyldopa
55-40-3

alpha-methyldopa

Conditions
ConditionsYield
With hydrogenchloride
L-Dopa ethyl ester hydrochloride
23234-41-5

L-Dopa ethyl ester hydrochloride

alpha-methyldopa
55-40-3

alpha-methyldopa

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 2.) K2CO3 / 2.) Acetone
2: 1.) solid KOH 2.) 1N HCl / 1.) tetrabutylammonium iodide / 1.) acetonitrile, 0 to 15 deg C 2.) ether, 0 deg C.
3: 1.) hydrogen 2.) 6N HCl / 1.) 10 percent Pd/C / 1.) ethanol
View Scheme
3-(3,4-Bis-benzyloxy-phenyl)-2-{[1-(2,4,6-trimethyl-phenyl)-meth-(Z)-ylidene]-amino}-propionic acid ethyl ester
84713-73-5

3-(3,4-Bis-benzyloxy-phenyl)-2-{[1-(2,4,6-trimethyl-phenyl)-meth-(Z)-ylidene]-amino}-propionic acid ethyl ester

alpha-methyldopa
55-40-3

alpha-methyldopa

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) solid KOH 2.) 1N HCl / 1.) tetrabutylammonium iodide / 1.) acetonitrile, 0 to 15 deg C 2.) ether, 0 deg C.
2: 1.) hydrogen 2.) 6N HCl / 1.) 10 percent Pd/C / 1.) ethanol
View Scheme
(±)-3-(3,4-dimethoxyphenyl)-2-amino-2-methylpropanenitrile
2543-46-6

(±)-3-(3,4-dimethoxyphenyl)-2-amino-2-methylpropanenitrile

alpha-methyldopa
55-40-3

alpha-methyldopa

Conditions
ConditionsYield
With water; hydrogen bromide
1-Fluoro-2-isocyanato-benzene
16744-98-2

1-Fluoro-2-isocyanato-benzene

alpha-methyldopa
55-40-3

alpha-methyldopa

3-(3,4-dihydroxyphenyl)-2-(3-(2-fluorophenyl)ureido)-2-methylpropanoic acid

3-(3,4-dihydroxyphenyl)-2-(3-(2-fluorophenyl)ureido)-2-methylpropanoic acid

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 40 - 50℃; for 3h; Catalytic behavior; Reagent/catalyst; Solvent;90%
alpha-methyldopa
55-40-3

alpha-methyldopa

4-bromophenyl isocyanate
2493-02-9

4-bromophenyl isocyanate

(3-(4-bromophenyl)ureido)-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid

(3-(4-bromophenyl)ureido)-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 40 - 50℃; for 3h;90%
alpha-methyldopa
55-40-3

alpha-methyldopa

o-trifluoromethyl-phenylisocyanate
2285-12-3

o-trifluoromethyl-phenylisocyanate

3-(3,4-dihydroxyphenyl)-2-methyl-2-(3-(2-(trifluoromethyl)phenyl)ureido)propanoic acid

3-(3,4-dihydroxyphenyl)-2-methyl-2-(3-(2-(trifluoromethyl)phenyl)ureido)propanoic acid

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 40 - 50℃; for 3h;90%
alpha-methyldopa
55-40-3

alpha-methyldopa

4-chloro-3-(trifluoromethyl)phenyl isocyanate
327-78-6

4-chloro-3-(trifluoromethyl)phenyl isocyanate

2-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid

2-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 40 - 50℃; for 3h;90%
alpha-methyldopa
55-40-3

alpha-methyldopa

m-chlorophenyl isocyanate
2909-38-8

m-chlorophenyl isocyanate

2-(3-(3-chlorophenyl)ureido)-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid

2-(3-(3-chlorophenyl)ureido)-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 40 - 50℃; for 3h;90%
cis-dichlorobis(triphenylphosphine)platinum(II)
10199-34-5, 14056-88-3, 15604-36-1

cis-dichlorobis(triphenylphosphine)platinum(II)

alpha-methyldopa
55-40-3

alpha-methyldopa

Pt(P(C6H5)3)2(O2C6H3CH2CCH3(NH2)COOH)*0.5CH2Cl2

Pt(P(C6H5)3)2(O2C6H3CH2CCH3(NH2)COOH)*0.5CH2Cl2

Conditions
ConditionsYield
With potassium hydroxide; dichloromethane In methanol; benzene to a suspn. of substituted catechol in benzene was added MeOH soln. of KOH; prepd. soln. was syringed into suspn. of Pt complex in benzene; stirring at room temp. for 3.5 h (Ar); filtration, evapn., washing with water, drying in vac., dissoln. in CH2Cl2, filtration, evapn., washing with ether, drying in vac.; elem. anal.;84%
alpha-methyldopa
55-40-3

alpha-methyldopa

chloroacetyl chloride
79-04-9

chloroacetyl chloride

N-Chloroacetyl-α-methyl-DOPA
121704-32-3

N-Chloroacetyl-α-methyl-DOPA

Conditions
ConditionsYield
In acetonitrile for 1.5h; Heating;60%
1-chloroethyl pivalate
40258-80-8

1-chloroethyl pivalate

alpha-methyldopa
55-40-3

alpha-methyldopa

A

α-methyldopa pivaloylethyl ester
81660-38-0

α-methyldopa pivaloylethyl ester

B

3-(3,4-Dihydroxy-phenyl)-2-[1-(2,2-dimethyl-propionyloxy)-ethylamino]-2-methyl-propionic acid 1-(2,2-dimethyl-propionyloxy)-ethyl ester
102108-09-8

3-(3,4-Dihydroxy-phenyl)-2-[1-(2,2-dimethyl-propionyloxy)-ethylamino]-2-methyl-propionic acid 1-(2,2-dimethyl-propionyloxy)-ethyl ester

Conditions
ConditionsYield
With 4 A molecular sieve In various solvent(s) at 75℃; for 8h; Product distribution; other temperature, various solvents; other alkylating agents; other amino acids; with or without LiBr;
alpha-methyldopa
55-40-3

alpha-methyldopa

2-Amino-3-(3,4-dioxo-cyclohexa-1,5-dienyl)-2-methyl-propionic acid
73688-25-2

2-Amino-3-(3,4-dioxo-cyclohexa-1,5-dienyl)-2-methyl-propionic acid

Conditions
ConditionsYield
With phenoloxidase from Lucilia cuprina pupae Enzyme kinetics; Oxidation;
With oxygen In phosphate buffer at 20℃; pH=6.8; Enzyme kinetics; Further Variations:; Reagents;
alpha-methyldopa
55-40-3

alpha-methyldopa

α-methyldopachrome
131923-54-1

α-methyldopachrome

Conditions
ConditionsYield
With sodium periodate In phosphate buffer for 0.166667h; pH=6.0; Oxidation; cyclization;
4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one
83-07-8

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one

alpha-methyldopa
55-40-3

alpha-methyldopa

potassium hexacyanoferrate(III)

potassium hexacyanoferrate(III)

[Fe(HOC6H2(O)(CH2C(CH3)(NH2)COOH)NHCC(O)N(C6H5)N(CH3)C(CH3))2(CN)(H2O)]
753453-85-9

[Fe(HOC6H2(O)(CH2C(CH3)(NH2)COOH)NHCC(O)N(C6H5)N(CH3)C(CH3))2(CN)(H2O)]

Conditions
ConditionsYield
In water hot aq. soln. of catecholamine was mixed with hot aq. soln. of 4-aminoantipyrine (60°C); mixt. was mixed with stirring with hot soln. of Fe compd. (60°C); mixt. was kept at room temp. for 6 h; filtered; washed (H2O, pentane); collected; dried in vac. over CaCl2; elem. anal.;
4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one
83-07-8

4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one

alpha-methyldopa
55-40-3

alpha-methyldopa

copper(II) sulfate
7758-99-8

copper(II) sulfate

[Cu(O2C6H2(CH2C(CH3)(NH2)COOH)NHCC(O)N(C6H5)N(CH3)C(CH3))(H2O)2]*4H2O

[Cu(O2C6H2(CH2C(CH3)(NH2)COOH)NHCC(O)N(C6H5)N(CH3)C(CH3))(H2O)2]*4H2O

Conditions
ConditionsYield
With ammonia In water ammonia soln. was added dropwise with stirring to soln. of Cu salt; hot (60°C) aq. soln. of catecholamine and hot (60°C) aq. soln.of 4-aminoantipyrine were added with stirring; concd.; kept in cupboard; filtered; washed (H2O, pentane); collected; dried in vac. over CaCl2; elem. anal.;
alpha-methyldopa
55-40-3

alpha-methyldopa

o-phthalic dicarboxaldehyde
643-79-8

o-phthalic dicarboxaldehyde

C28H28N2O8

C28H28N2O8

Conditions
ConditionsYield
Stage #1: alpha-methyldopa With potassium hydroxide In methanol; ethanol for 1h;
Stage #2: o-phthalic dicarboxaldehyde In methanol; ethanol for 2h;
alpha-methyldopa
55-40-3

alpha-methyldopa

o-phthalic dicarboxaldehyde
643-79-8

o-phthalic dicarboxaldehyde

C28H30CrN2O10*H2O

C28H30CrN2O10*H2O

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: potassium hydroxide / methanol; ethanol / 1 h
1.2: 2 h
2.1: methanol / 2 h / Reflux
View Scheme
manganese(II) chloride hydrate

manganese(II) chloride hydrate

alpha-methyldopa
55-40-3

alpha-methyldopa

aspirin
50-78-2

aspirin

C19H23MnNO10

C19H23MnNO10

Conditions
ConditionsYield
With potassium hydroxide In ethanol for 2h; Heating;
iron(II) chloride hydrate

iron(II) chloride hydrate

alpha-methyldopa
55-40-3

alpha-methyldopa

aspirin
50-78-2

aspirin

C19H23FeNO10

C19H23FeNO10

Conditions
ConditionsYield
With potassium hydroxide In ethanol for 2h; Heating;
cobalt(II) chloride hydrate

cobalt(II) chloride hydrate

alpha-methyldopa
55-40-3

alpha-methyldopa

aspirin
50-78-2

aspirin

C19H23CoNO10

C19H23CoNO10

Conditions
ConditionsYield
With potassium hydroxide In ethanol for 2h; Heating;
nickel(II) dichloride hydrate

nickel(II) dichloride hydrate

alpha-methyldopa
55-40-3

alpha-methyldopa

aspirin
50-78-2

aspirin

C19H23NNiO10

C19H23NNiO10

Conditions
ConditionsYield
With potassium hydroxide In ethanol for 2h; Heating;
copper(II) chloride hydrate

copper(II) chloride hydrate

alpha-methyldopa
55-40-3

alpha-methyldopa

aspirin
50-78-2

aspirin

C19H23CuNO10

C19H23CuNO10

Conditions
ConditionsYield
With potassium hydroxide In ethanol for 2h; Heating;
manganese(II) chloride hydrate

manganese(II) chloride hydrate

4-acetaminophenol
103-90-2

4-acetaminophenol

alpha-methyldopa
55-40-3

alpha-methyldopa

C18H24MnN2O8

C18H24MnN2O8

Conditions
ConditionsYield
With potassium hydroxide In ethanol for 2h; Heating;
iron(II) chloride hydrate

iron(II) chloride hydrate

4-acetaminophenol
103-90-2

4-acetaminophenol

alpha-methyldopa
55-40-3

alpha-methyldopa

C18H24FeN2O8

C18H24FeN2O8

Conditions
ConditionsYield
With potassium hydroxide In ethanol for 2h; Heating;

55-40-3Relevant articles and documents

Multiple molecular targets mediated antioxidant activity, molecular docking, ADMET, QSAR and bioactivity studies of halo substituted urea derivatives of α-Methyl-L-DOPA

Anireddy, Jaya Shree,Avula, Vijaya Kumar Reddy,Chamarthi, Naga Raju,Mallepogu, Venkataswamy,Pasupuleti, Visweswara Rao,Ponne, Venkata Chalapathi,Vadabingi, Nagalakshmamma,Vallela, Swetha,Zyryanov, Grigory V.

, (2020/03/13)

A series of novel α-methyl-L-DOPA urea derivatives viz., 3-(3,4-dihydroxyphenyl)-2-methyl-2-(3-halo/trifluoromethyl substituted phenyl ureido)propanoic acids (6a-e) have been synthesized from the reaction of α-methyl-L-DOPA (3) with various aryl isocyanates (4a-e) by using triethylamine (5, TEA) as a base catalyst in THF at reflux conditions. The synthesized compounds are structurally characterized by spectral (IR, 1H & 13C NMR and MASS) and elemental analysis studies and screened for their in-vitro antioxidant activity against DPPH, NO and H2O2 free radical scavenging assays and identified compounds 6c & 6d as potential antioxidants. The acquired in vitro results were correlated with the results of molecular docking, ADMET, QSAR and bioactivity studies performed for them and predicted that the recorded in silico binding affinities are in good correlation with the in vitro antioxidant activity results. The molecular docking analysis has comprehended the strong hydrogen bonding interactions of 6a-e with 1CB4, 1N8Q, 3MNG, 1OG5, 1DNU, 3NRZ, 2CDU, 1HD2 and 2HCK proteins of their respective SOD, LO, PRXS5, CP450, MP, XO, NO, PRY5 and HCK enzymes. This has sustained the effective binding of 6a-e and resulted in functional inhibition of selective aminoacid residues to be pronounced as multiple molecular targets mediated antioxidant potent compounds. In addition, the evaluated toxicology risks of 6a-e are identified with in the potential limits of drug candidates. The conformational analysis of 6c & 6d prominently infers that urea moiety uniting α-methyl-L-DOPA with halo substituted aryl units into a distinctive orientation to comply good structure-activity to inhibit the proliferation of reactive oxygen species in vivo.

Studies on optically active amino acids. VI. Studies on alpha-alkyl-alpha-amino acids. II. Resolution of some alpha-methyl-alpha-amino acids through 1-menthyl ester.

Terashima,Achiwa,Yamada

, p. 1399 - 1407 (2007/10/05)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 55-40-3